Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
“Blue-chips opened in positive territory ahead of UK Prime Minister Theresa May power lunch with European Commission president, Jean-Claude Juncker, as Britain sets out its latest deal to enable trade talks to commence,” says AJ Bell Investment Director Russ Mould.
“National Express was an early riser after it completed two small acquisitions in the US and Spain and affirmed its full year guidance. The group has seen strong early Christmas trading in both its UK and Spanish coach businesses, with advanced sales higher than last year and it remains on course to deliver its profit, free cash flow and leverage targets for the full year. The group’s shares were up by more than 2.5%.
“Pharmaceutical group Circassia topped the FTSE All-Share list after positive results from a post-marketing study of Tudorza for the treatment of patients with moderate to very severe chronic obstructive pulmonary disease. Tudorza showed a significant reduction in symptoms and also demonstrated a favourable cardiovascular safety profile. Circassia and AstraZeneca are collaborating on Tudorza with Circassia having responsibility for marketing it in the US while AstraZeneca is responsible for conducting the product's clinical studies. Circassia’s shares were up by over 9.1%.
“Galileo Resources’ shares were up in early trading after it confirmed that drilling was set to start at its 51% owned Star zinc project in Zambia. The drill programme, which aims to both confirm and enlarge the resources at the project, is in line with the Galileo’s stated objective to fast track exploration. Galileo’s share were up by more than 7.8%.”
These articles are for information purposes only and are not a personal recommendation or advice.